Search - Enter Keyword
 
Dangerous Drugs
Avandia
Accutane
Vioxx
Crestor
Bextra
Fen Phen
Fosamax
Ephedra
Raptiva
Serzone
Seroquel
Trasylol
Permax
Remicade
Contraceptives
Celebrex
Anti-Depressants
Paxil
Strattera
Fentanyl
Digitek
Serevent
COX-2 Inhibitors
Defective Medical Devices
Medtronic Sprint Fidelis Defibrillator Leads
Guidant Defibrillators
Zimmer Durom Cup
Kugel Mesh Patch
Guidant Ancure Device
Toxic Substances
Welding Rods
Asbestos
Mesothelioma
Lead Poisoning
Medical Malpractice
Cerebral Palsy
Erb's Palsy
Birth Injury
Surgical Mistake
Cancer Misdiagnosis
Nursing Home Negligence
Hospital Negligence
Accidents
Car Accidents
Plane Accidents
Boat Accidents
Bus Accidents
Motorcycle Accidents
Brain Injury
Yamaha Rhino Rollover Injury
Spinal Cord Injury
Dodge Truck and SUV Recall
Other Injuries
Slip and Fall
Insurance Bad Faith
Dog Bite Injury
Inadequate Security
Recall Forum
Consumer Products
Sexual Abuse
Product Liability
General Inquiries

Rezulin

Find out if you have a claim against the Rezulin manufacturer

Rezulin, the brand name for troglitazone, was a prescription drug that helped diabetics utilize insulin in the bloodstream. For those diabetics with adult-onset (Type 2) diabetes who had built a resistance to insulin, Rezulin was designed to reduce the amount of sugar produced by the liver and control the body's blood sugar levels.

For the more than 500,000 people with Type 2 Diabetes who received Rezulin, the drug was promoted as the alternative to daily insulin injections that the diabetics required to survive. Warner-Lambert, the manufacturer of Rezulin, requested and received fast track approval of Rezulin, and the drug made its way through the quickest approval process for a diabetes drug in the history of the Federal Drug Administration (FDA).

In October of 1997, there were reports of serious Rezulin side effects, including 35 cases of liver damage related to Rezulin, two ending in death. These findings led Warner-Lambert to recommend that physicians monitor their patients' liver condition by testing enzyme levels five times during the first year. When this failed to prevent Rezulin-related liver damage, Warner-Lambert raised the warning to ten exams for the first year.

On May 19, 2000, the FDA finally requested the withdrawal of Rezulin. At that time, Rezulin was associated with 90 confirmed reports of liver failure and 63 deaths. Many people who took Rezulin have suffered severe liver damage resulting in death or the need for a liver transplant. It is feared that hundreds more have sustained permanent liver damage from Rezulin use without even knowing it.

The symptoms of Rezulin-induced liver damage include jaundice (yellow skin or eyes), dark urine, nausea, vomiting, abdominal pain, fatigue, and loss of appetite. These may be early signs of liver damage. Blood tests to monitor your liver function should be administered to determine if you have suffered any liver damage. If you suspect that you have been injured through the use of Rezulin and have questions or concerns, please call our experienced Rezulin lawyers at 1-800-THE-EAGLE (1-800-843-3245) or SUBMIT A SHORT AND SIMPLE CASE FORM HERE. You may have a Rezulin lawsuit and be entitled to compensation for your injuries.

***WE ARE NO LONGER ACCEPTING NEW REZULIN CASES AT THIS TIME***

Resources:
Rezulin Articles
Rezulin Related Books
Rezulin Summary
More Information:
Rezulin Side Effects
Rezulin Law Suit News
Lifecycle of Rezulin